Bessemer Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-83
| Closed | -$18K | – | 1679 |
|
|
2021
Q1 | $18K | Buy |
83
+77
| +1,283% | +$14.5K | ﹤0.01% | 1204 |
|
|
2020
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 1574 |
|
|
2020
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 1326 |
|
|
2020
Q2 | $1K | Buy |
+6
| New | +$681 | ﹤0.01% | 1683 |
|
|
2018
Q4 | – | Sell |
-15
| Closed | -$3K | – | 2101 |
|
|
2018
Q3 | $3K | Hold |
15
| – | – | ﹤0.01% | 1749 |
|
|
2018
Q2 | $2K | Hold |
15
| – | – | ﹤0.01% | 1636 |
|
|
2018
Q1 | $2K | Hold |
15
| – | – | ﹤0.01% | 1613 |
|
|
2017
Q4 | $2K | Hold |
15
| – | – | ﹤0.01% | 1643 |
|
|
2017
Q3 | $2K | Hold |
15
| – | – | ﹤0.01% | 1747 |
|
|
2017
Q2 | $2K | Hold |
15
| – | – | ﹤0.01% | 1765 |
|
|
2017
Q1 | $2K | Hold |
15
| – | – | ﹤0.01% | 1693 |
|
|
2016
Q4 | $2K | Buy |
+15
| New | +$1.8K | ﹤0.01% | 1872 |
|
|
2016
Q1 | – | Sell |
-165
| Closed | -$11K | – | 1726 |
|
|
2015
Q4 | $11K | Buy |
165
+65
| +65% | +$5.29K | ﹤0.01% | 1211 |
|
|
2015
Q3 | $9K | Hold |
100
| – | – | ﹤0.01% | 1234 |
|
|
2015
Q2 | $12K | Hold |
100
| – | – | ﹤0.01% | 1212 |
|
|
2015
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 1245 |
|
|
2014
Q4 | $7K | Hold |
100
| – | – | ﹤0.01% | 1322 |
|
|
2014
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 1109 |
|
|
2014
Q2 | $11K | Buy |
+100
| New | +$6.95K | ﹤0.01% | 1084 |
|
Other funds holding GWPH
Bessemer Group's GWPH Position: Q2 2021 in Review
Bessemer Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 83 shares — an estimated $18K sold.
Bessemer Group first reported a position in GWPH in Q2 2014 and held it in 19 quarters. The position peaked at $18K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Bessemer Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Bessemer Group sold 83 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $18K.
- Bessemer Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 19 quarters.
- Bessemer Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $18K in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Bessemer Group's 13F filing for Q2 2021, filed 6 Aug 2021.